These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7826212)
1. The nucleoprotein of Pichinde virus expressed by a vaccinia-Pichinde virus recombinant partially protects hamsters from lethal virus challenge. Ozols DY; Rawls WE; Rosenthal KL; Harnish DG Arch Virol; 1994; 139(1-2):23-36. PubMed ID: 7826212 [TBL] [Abstract][Full Text] [Related]
2. Variation between strains of hamsters in the lethality of Pichinde virus infections. Buchmeier MJ; Rawls WE Infect Immun; 1977 May; 16(2):413-21. PubMed ID: 193786 [TBL] [Abstract][Full Text] [Related]
3. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231 [TBL] [Abstract][Full Text] [Related]
4. Association of reduced interleukin-2 production with genetic susceptibility to Pichinde virus in inbred strains of hamsters. Wright KE; Rosenthal KL; Rawls WE Arch Virol; 1987; 92(3-4):197-209. PubMed ID: 3028332 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility to fatal Pichinde virus infection in the Syrian hamster. Gee SR; Chan MA; Clark DA; Rawls WE Adv Exp Med Biol; 1981; 134():327-38. PubMed ID: 6261541 [TBL] [Abstract][Full Text] [Related]
6. A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge. Bukreyev A; Yang L; Zaki SR; Shieh WJ; Rollin PE; Murphy BR; Collins PL; Sanchez A J Virol; 2006 Mar; 80(5):2267-79. PubMed ID: 16474134 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions. Huang Q; Shao J; Lan S; Zhou Y; Xing J; Dong C; Liang Y; Ly H J Virol; 2015 Jul; 89(13):6595-607. PubMed ID: 25878103 [TBL] [Abstract][Full Text] [Related]
8. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340 [TBL] [Abstract][Full Text] [Related]
9. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Hevey M; Negley D; Pushko P; Smith J; Schmaljohn A Virology; 1998 Nov; 251(1):28-37. PubMed ID: 9813200 [TBL] [Abstract][Full Text] [Related]
11. Immunizing effect of vaccinia virus expressing the nucleoprotein of rinderpest virus on systemic rinderpest virus infection in rabbits. Nakamura K; Ohishi K; Ohkubo S; Kamata H; Yamanouchi K; Fujiwara K; Kai C Comp Immunol Microbiol Infect Dis; 1998 Apr; 21(2):91-9. PubMed ID: 9611679 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the specificity of cytotoxic T lymphocytes for the nucleoprotein of Pichinde virus using recombinant vaccinia viruses. Ozols DY; Harnish DG; Rawls WE; Rosenthal KL Arch Virol; 1990; 115(3-4):209-25. PubMed ID: 1701987 [TBL] [Abstract][Full Text] [Related]
13. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. Chu YK; Jennings GB; Schmaljohn CS J Virol; 1995 Oct; 69(10):6417-23. PubMed ID: 7666542 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein. Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608 [TBL] [Abstract][Full Text] [Related]
15. Pichinde virus-specific cell-associated suppression of primary footpad swelling in an inbred strain of Syrian hamsters. Chan M; Clark D; Rawls WE J Immunol; 1983 Feb; 130(2):925-31. PubMed ID: 6184408 [TBL] [Abstract][Full Text] [Related]
17. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence. Shao J; Liu X; Ly H; Liang Y J Virol; 2016 Nov; 90(22):10390-10397. PubMed ID: 27630230 [TBL] [Abstract][Full Text] [Related]
19. Role of natural killer cells in Pichinde virus infection of Syrian hamsters. Gee SR; Chan MA; Clark DA; Rawls WE Infect Immun; 1981 Mar; 31(3):919-28. PubMed ID: 6262252 [TBL] [Abstract][Full Text] [Related]
20. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]